{
    "id": 27311,
    "fullName": "EGFR H773_V774dup",
    "impact": "duplication",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "EGFR H773_V774dup (also referred to as P772_H773insHV) indicates the insertion of 2 duplicate amino acids, histidine (H)-773 through valine (V)-774, in the protein kinase domain of the Egfr protein (UniProt.org). H773_V774dup has not been biochemically characterized, but is predicted to lead to Egfr activation based on the effect of other Egfr exon 20 insertions (PMID: 24353160, PMID: 16187797).",
            "references": [
                {
                    "id": 410,
                    "pubMedId": 16187797,
                    "title": "Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16187797"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 440,
                    "pubMedId": 24353160,
                    "title": "Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24353160"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "H773_V774dup",
    "createDate": "11/28/2017",
    "updateDate": "07/22/2019",
    "referenceTranscriptCoordinates": {
        "id": 135683,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55181326_55181331",
        "cDna": "c.2317_2322",
        "protein": "p.H773_V774",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20925,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells expressing the EGFR exon 20 insertion H773_V774dup were resistant to Tagrisso (osimertinib) in culture (PMID: 24893891).",
            "molecularProfile": {
                "id": 28734,
                "profileName": "EGFR H773_V774dup"
            },
            "therapy": {
                "id": 660,
                "therapyName": "Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 537,
                    "pubMedId": 24893891,
                    "title": "AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24893891"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 20101,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Tarceva (erlotinib) treatment resulted in progressive disease with a progression-free survival of 4 months in a patient with non-small cell lung cancer harboring EGFR H773_V774dup (PMID: 31715539).",
            "molecularProfile": {
                "id": 28734,
                "profileName": "EGFR H773_V774dup"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17697,
                    "pubMedId": 31715539,
                    "title": "Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31715539"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28734,
            "profileName": "EGFR H773_V774dup",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 135683,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55181326_55181331",
            "cDna": "c.2317_2322",
            "protein": "p.H773_V774",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}